Enliven Therapeutics (ELVN) Cash & Current Investments (2019 - 2026)
Enliven Therapeutics' Cash & Current Investments came in at $895.16 million for Q2 2026, up 82.5% from $490.5 million a year earlier and up 97.9% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Cash & Current Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Enliven Therapeutics' Cash & Current Investments was $462.62 million, up 47.6% from FY2024.
- Cash & Current Investments has increased in each of the last three years, with a five-year compound annual growth rate of 39.3% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $313.44 million in FY2024 (+23.8%), $253.15 million in FY2023 (+235.1%), $75.54 million in FY2022 (-16.3%) and $90.28 million in FY2021 (+2.3%).
- The Q2 2026 figure represents the highest quarterly Cash & Current Investments in data going back to Q1 2019.
- Year-over-year, Cash & Current Investments has increased for five consecutive quarters, with growth averaging 41.5% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2023 (growth of 235.1%), and the weakest in Q4 2022 (a decline of 16.3%).
- Business Quant data shows ELVN's Cash & Current Investments at $452.4 million (Q1 2026), $462.62 million (Q4 2025) and $477.57 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Enliven Therapeutics | 3.04 Bn | 753.67 Mn | - | 895.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 895.16 Mn |
| Mar 31, 2026 | 452.40 Mn |
| Dec 31, 2025 | 462.62 Mn |
| Sep 30, 2025 | 477.57 Mn |
| Jun 30, 2025 | 490.50 Mn |
| Mar 31, 2025 | 289.56 Mn |
| Dec 31, 2024 | 313.44 Mn |
| Sep 30, 2024 | 291.83 Mn |
| Jun 30, 2024 | 312.39 Mn |
| Mar 31, 2024 | 320.50 Mn |
| Dec 31, 2023 | 253.15 Mn |
| Sep 30, 2023 | 263.48 Mn |
| Jun 30, 2023 | 277.87 Mn |
| Mar 31, 2023 | 292.10 Mn |
| Dec 31, 2022 | 75.54 Mn |
| Sep 30, 2022 | 92.97 Mn |
| Jun 30, 2022 | 122.36 Mn |
| Mar 31, 2022 | 136.29 Mn |
| Dec 31, 2021 | 90.28 Mn |
| Sep 30, 2021 | 102.84 Mn |
API Access
Enliven Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();